Matthew Harrison
Stock Analyst at Morgan Stanley
(3.22)
# 1,066
Out of 4,734 analysts
725
Total ratings
45.92%
Success rate
1.68%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintains: Equal-Weight | $70 → $38 | $34.06 | +11.57% | 24 | Jan 15, 2025 | |
| GILD Gilead Sciences | Upgrades: Overweight | $87 → $113 | $91.84 | +23.04% | 38 | Jan 10, 2025 | |
| ALEC Alector | Downgrades: Underweight | $10 → $3 | $1.71 | +75.44% | 10 | Nov 26, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $473 → $476 | $422.00 | +12.80% | 36 | Nov 5, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $1,235 → $1,184 | $681.58 | +73.71% | 50 | Nov 1, 2024 | |
| BIIB Biogen | Downgrades: Equal-Weight | $285 → $204 | $140.55 | +45.14% | 50 | Oct 31, 2024 | |
| AVNT Avient | Downgrades: Neutral | n/a | $42.44 | - | 1 | Oct 18, 2024 | |
| IOBT IO Biotech | Maintains: Overweight | $4 → $6 | $0.84 | +617.19% | 5 | Sep 16, 2024 | |
| AVIR Atea Pharmaceuticals | Upgrades: Equal-Weight | $2 → $6.88 | $3.37 | +104.15% | 9 | Aug 13, 2024 | |
| TSVT 2seventy bio | Maintains: Equal-Weight | $7 → $6 | $2.61 | +129.89% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $85 | $72.51 | +17.23% | 15 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $165 → $200 | $118.00 | +69.49% | 34 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $15.16 | -27.44% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $2.24 | +257.14% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $640.52 | -20.38% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $1.22 | +473.77% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $61.53 | +82.03% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $18.36 | +85.19% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $20.80 | +53.85% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $2.89 | +557.44% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $14 | $1.40 | +900.00% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 → $85 | $32.66 | +160.26% | 10 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $60 | $8.35 | +618.56% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $36.58 | +25.75% | 1 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $61 → $63 | $21.93 | +187.28% | 11 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $1.93 | +573.58% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.41 | +146.06% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $18.58 | -46.18% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $3.96 | +102.02% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $23.76 | +85.19% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.16 | +311.39% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $0.58 | +595.05% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.51 | +485.25% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $111.93 | +92.98% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $1.83 | +173.22% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.84 | +171.74% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $171.56 | +6.09% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $7.17 | +25.52% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $25.14 | +59.11% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $272.11 | +3.63% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $246.27 | -14.73% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $27 | $9.28 | +190.95% | 7 | Sep 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $26.30 | +97.72% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $147.03 | +17.66% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $7.08 | +705.08% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $40.00 | +200.00% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $37.59 | +293.72% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $97.92 | -16.26% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $56.29 | +17.25% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $1.53 | +2,449.02% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $30.75 | +49.59% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $15.74 | +122.36% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $725.72 | -62.11% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $1.71 | +1,011.11% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $7.37 | +741.25% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $17.01 | +1.41% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $1.73 | +2,790.17% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $71.93 | +15.39% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $12.74 | +347.41% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $45.74 | -78.14% | 4 | Sep 10, 2018 |
Moderna
Jan 15, 2025
Maintains: Equal-Weight
Price Target: $70 → $38
Current: $34.06
Upside: +11.57%
Gilead Sciences
Jan 10, 2025
Upgrades: Overweight
Price Target: $87 → $113
Current: $91.84
Upside: +23.04%
Alector
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.71
Upside: +75.44%
Vertex Pharmaceuticals
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $473 → $476
Current: $422.00
Upside: +12.80%
Regeneron Pharmaceuticals
Nov 1, 2024
Maintains: Overweight
Price Target: $1,235 → $1,184
Current: $681.58
Upside: +73.71%
Biogen
Oct 31, 2024
Downgrades: Equal-Weight
Price Target: $285 → $204
Current: $140.55
Upside: +45.14%
Avient
Oct 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $42.44
Upside: -
IO Biotech
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $0.84
Upside: +617.19%
Atea Pharmaceuticals
Aug 13, 2024
Upgrades: Equal-Weight
Price Target: $2 → $6.88
Current: $3.37
Upside: +104.15%
2seventy bio
Jul 29, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $2.61
Upside: +129.89%
Jul 12, 2024
Maintains: Overweight
Price Target: $60 → $85
Current: $72.51
Upside: +17.23%
Jun 24, 2024
Maintains: Overweight
Price Target: $165 → $200
Current: $118.00
Upside: +69.49%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $15.16
Upside: -27.44%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $2.24
Upside: +257.14%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $640.52
Upside: -20.38%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $1.22
Upside: +473.77%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $61.53
Upside: +82.03%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $18.36
Upside: +85.19%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $20.80
Upside: +53.85%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $2.89
Upside: +557.44%
Aug 10, 2023
Maintains: Overweight
Price Target: $13 → $14
Current: $1.40
Upside: +900.00%
Jul 20, 2023
Maintains: Overweight
Price Target: $65 → $85
Current: $32.66
Upside: +160.26%
Jul 11, 2023
Reiterates: Underweight
Price Target: $60
Current: $8.35
Upside: +618.56%
Apr 24, 2023
Reiterates: Buy
Price Target: $46
Current: $36.58
Upside: +25.75%
Apr 12, 2023
Maintains: Overweight
Price Target: $61 → $63
Current: $21.93
Upside: +187.28%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $1.93
Upside: +573.58%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.41
Upside: +146.06%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $18.58
Upside: -46.18%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $3.96
Upside: +102.02%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $23.76
Upside: +85.19%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.16
Upside: +311.39%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $0.58
Upside: +595.05%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.51
Upside: +485.25%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $111.93
Upside: +92.98%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.83
Upside: +173.22%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.84
Upside: +171.74%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $171.56
Upside: +6.09%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $7.17
Upside: +25.52%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $25.14
Upside: +59.11%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $272.11
Upside: +3.63%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $246.27
Upside: -14.73%
Sep 9, 2022
Maintains: Overweight
Price Target: $32 → $27
Current: $9.28
Upside: +190.95%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $26.30
Upside: +97.72%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $147.03
Upside: +17.66%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $7.08
Upside: +705.08%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $40.00
Upside: +200.00%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $37.59
Upside: +293.72%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $97.92
Upside: -16.26%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $56.29
Upside: +17.25%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $1.53
Upside: +2,449.02%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $30.75
Upside: +49.59%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $15.74
Upside: +122.36%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $725.72
Upside: -62.11%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $1.71
Upside: +1,011.11%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $7.37
Upside: +741.25%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.01
Upside: +1.41%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $1.73
Upside: +2,790.17%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $71.93
Upside: +15.39%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $12.74
Upside: +347.41%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $45.74
Upside: -78.14%